TP53 and breast cancer: This notion is supported by the fact that we cannot find specific MMTV insertions in mammary tumor-prone mice with heterozygous Pten deletion or tissue-specific loss of Trp53, even though MMTV-infected Pten heterozygous mice developed mammary tumors faster than their wild-type counterparts.